-
My Account
In App
My Account
BSE Live
Oct 27, 13:54Prev. Close
140.00
Open Price
138.20
Bid Price (Qty.)
133.40 (14)
Offer Price (Qty.)
136.20 (306)
NSE Live
Oct 27, 13:57Prev. Close
140.60
Open Price
140.60
Bid Price (Qty.)
135.01 (8)
Offer Price (Qty.)
135.31 (8)
| Balance Sheet of Indo US Bio-Tech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 20.05 | 20.05 | 10.03 | 9.17 | 6.07 | |
| Total Share Capital | 20.05 | 20.05 | 10.03 | 9.17 | 6.07 | |
| Reserves and Surplus | 58.47 | 42.70 | 44.47 | 29.71 | 15.47 | |
| Total Reserves and Surplus | 58.47 | 42.70 | 44.47 | 29.71 | 15.47 | |
| Total Shareholders Funds | 78.52 | 62.75 | 54.50 | 38.88 | 21.54 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 2.93 | 2.80 | 1.70 | 3.40 | 3.31 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 1.40 | 0.93 | 1.05 | 0.79 | |
| Long Term Provisions | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | |
| Total Non-Current Liabilities | 2.99 | 4.25 | 2.68 | 4.49 | 4.13 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 11.90 | 11.52 | 9.89 | 9.11 | 7.19 | |
| Trade Payables | 1.16 | 4.39 | 1.40 | 2.55 | 8.82 | |
| Other Current Liabilities | 3.27 | 1.20 | 0.90 | 0.45 | 1.64 | |
| Short Term Provisions | 0.00 | 0.35 | 0.10 | 0.10 | 0.37 | |
| Total Current Liabilities | 16.34 | 17.46 | 12.29 | 12.21 | 18.01 | |
| Total Capital And Liabilities | 97.84 | 84.46 | 69.47 | 55.57 | 43.68 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 10.23 | 6.69 | 7.37 | 5.54 | 2.33 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 3.78 | 1.37 | 2.32 | 1.99 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 10.23 | 10.47 | 8.73 | 7.86 | 4.32 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Deferred Tax Assets [Net] | 0.70 | 0.66 | 0.58 | 0.42 | 0.26 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.25 | 0.94 | |
| Other Non-Current Assets | 0.19 | 0.24 | 0.24 | 0.23 | 0.01 | |
| Total Non-Current Assets | 11.12 | 11.36 | 9.56 | 8.77 | 5.55 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 70.69 | 51.74 | 26.91 | 23.36 | 11.88 | |
| Trade Receivables | 15.00 | 19.05 | 24.74 | 20.54 | 24.69 | |
| Cash And Cash Equivalents | 0.25 | 1.10 | 0.19 | 0.05 | 0.13 | |
| Short Term Loans And Advances | 0.75 | 1.18 | 8.05 | 2.81 | 1.37 | |
| OtherCurrentAssets | 0.04 | 0.03 | 0.02 | 0.05 | 0.05 | |
| Total Current Assets | 86.73 | 73.09 | 59.91 | 46.80 | 38.13 | |
| Total Assets | 97.84 | 84.46 | 69.47 | 55.57 | 43.68 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1.17 | 0.98 | 1.19 | 0.70 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 13.18 | 13.18 | 3.15 | 0.31 | 3.15 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017
